·	The studies compared those who used Resperate Breath Control Blood Pressure Lowering Device for 15 minutes a day for 8 weeks to a control group, using a walkman with relaxing music1, home blood pressure monitoring or both

·	Clinical studies design included four double-blind and randomized, one controlled and randomized, and two open-label studies

·	There were 286 participants, average age of 58.

·	78% of participants were already taking blood pressure medications, a third of whom were taking more than 3 medications.

·	The average initial office blood pressure was 150/90 mmHg despite using diet, exercise and/or medications.

·	Resperate Breath Control Blood Pressure Lowering Device users with uncontrolled blood pressure (BP) experienced a significant decrease in office blood pressure with average reduction of 14/8 mmHg.

·	Control treatment reduction was 9/4 mmHg, significantly less than with Resperate Breath Control Blood Pressure Lowering Device (p = 0.008 and p = 0.002, respectively for systolic and diastolic blood pressures).

·	The results were similar across genders and medication status.

·	The drop in office BP was directly related to the duration of slow breathing; those who used Resperate Breath Control Blood Pressure Lowering Device more achieved better reductions.

·	A sustained reduction in blood pressure typically occurred in 3 to 5 weeks.

·	Larger reductions in office blood pressure occurred in older individuals and those with higher baseline blood pressures, whether taking antihypertensive medication or not.

·	Home blood pressure measurements (for up to 6 months of use7) and 24-hours ambulatory blood pressure monitoring5 have verified an all-day, lasting blood pressure lowering effect.

·	Patients' ability to operate the Resperate Breath Control Blood Pressure Lowering Device device without prior training and to comply with routine use were established objectively using the device's internal memory and verified by post-market surveys.